No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Dec 9, 2019

The Week in Review in Prescription Drug Pricing

Waiting on PhRMA to announce its plan to lower drug prices like…

Read Article
News Nov 25, 2019

The Week in Review in Prescription Drug Pricing

Letting academic medical centers make CAR-T drugs would save billions. — (STAT Op-Ed)

Read Article
News Nov 18, 2019

The Week in Review in Prescription Drug Pricing

In recognition of World Diabetes Day, P4AD released a new report that tells the story of how the insulin pricing crisis came to be and what we must do to fix it. — (P4AD & NBC)

Read Article
News Nov 12, 2019

The Week in Review in Prescription Drug Pricing

It’s a good week when the government stands up to Big Pharma patent predators.

Read Article
News Nov 4, 2019

The Week in Review in Prescription Drug Pricing

Dr. Peter Bach explains how the U.S. can lower drug prices at little cost to drug discovery. — (Bloomberg)

Read Article
News Oct 28, 2019

The Week in Review in Prescription Drug Pricing

Will Washington take a swing at lowering drug prices? Senate, House, and Administration reforms would be a home run for patients.

Read Article
News Oct 23, 2019

Momentum Builds For Bipartisan Reforms To Lower Drug Prices

As millions of Americans demand lower drug prices, momentum continues to build for policy changes out of the House and Senate.

Read Article
News Oct 21, 2019

The Week in Review in Prescription Drug Pricing

A sweeping Medicare negotiation bill saw hearings and markups this week. It’s moving, folks! — (Los Angeles Times)

Read Article
News Oct 17, 2019

Patients Win in Whirlwind Day for Drug Pricing

In response to votes in the House Energy & Commerce Committee and the House Education & Labor Committee to advance H.R. 3, a bill that would lower drug prices for all insured Americans through…

Read Article
News Oct 14, 2019

The Week in Review in Prescription Drug Pricing

If the Nats can make the NLCS without Bryce Harper, surely Washington can pass drug pricing reform by the end of the year.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.